(Q50850165)
Statements
Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides. (English)
1 reference
François Spertini
1 reference
Yannick Perrin
1 reference
Régine Audran
1 reference
Céline Pellaton
1 reference
Caroline Boudousquié
1 reference
Nathalie Barbier
1 reference
Anne-Christine Thierry
1 reference
Vincent Charlon
1 reference
Christophe Reymond
1 reference
3 May 2014
1 reference
134
1 reference
1
1 reference
239-240.e13
1 reference